Literature DB >> 35221759

Investigation of the Subcellular Localization-Dependent Anti- or Pro-Tumor Functions of Maspin in Human Lung Adenocarcinoma Cell Line.

Takahiro Matsushige1, Tomohiko Sakabe1, Yoshihisa Umekita1.   

Abstract

BACKGROUND: Mammary serine protease inhibitor (maspin) is well known as a tumor suppressor gene in several types of cancers and its nuclear localization is essential for its tumor-suppressive function. We previously reported that the cytoplasmic-only localization of maspin is significantly correlated with unfavorable prognosis in patients with lung adenocarcinoma (LUAD). To clarify whether maspin in LUAD acts as a tumor promoter or suppressor, we examined the subcellular localization-dependent biological functions of maspin in human LUAD cell lines.
METHODS: The expression levels and subcellular localization of maspin were investigated by performing immunoblotting and immunofluorescence in human LUAD cell lines (PC-9, A549, NCI-H23, RERF-LC-KJ) and human bronchial epithelial cell line (BEAS-2B). We then established stable cell lines overexpressing maspin (A549-maspin and RERF-LC-KJ-maspin) and investigated their subcellular localization. Cell invasion assays of these cell lines were performed to examine their invasiveness. Moreover, the mRNA expression levels between epithelial cell markers (E-cadherin) and mesenchymal cell markers (N-cadherin and vimentin) were compared.
RESULTS: The expression of maspin in PC-9 cells was comparable to that in BEAS-2B cells, whereas its expression in A549, NCI-H23, and RERF-LC-KJ cells was decreased. The cell invasion capability of A549-maspin cells showing pancellular expression was significantly decreased compared with that of A549-control cells. By contrast, the cell invasion capability of RERF-LC-KJ-maspin cells showing cytoplasmic-only expression was significantly increased compared with that of RERF-LC-KJ-control cells. The mRNA expression levels of N-cadherin, but not E-cadherin and vimentin, in A549-maspin cells was significantly downregulated compared with that in A549-control cells. No significant differences in these markers were observed between RERF-LC-KJ-maspin and RERF-LC-KJ-control cells.
CONCLUSION: The invasive capability of LUAD cells is regulated by the intracellular localization of maspin. Clarification of the molecular mechanism underlying the subcellular localization-dependent function of maspin will promote a deeper understanding of LUAD development and progression. ©2022 Tottori University Medical Press.

Entities:  

Keywords:  lung adenocarcinoma; maspin

Year:  2022        PMID: 35221759      PMCID: PMC8857674          DOI: 10.33160/yam.2022.02.006

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  40 in total

1.  N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells.

Authors:  G Li; K Satyamoorthy; M Herlyn
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

2.  Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.

Authors:  Marcus Bettstetter; Matthias Woenckhaus; Peter J Wild; Petra Rümmele; Hagen Blaszyk; Arndt Hartmann; Ferdinand Hofstädter; Wolfgang Dietmaier
Journal:  J Pathol       Date:  2005-04       Impact factor: 7.996

3.  Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.

Authors:  H Biliran; S Sheng
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.

Authors:  H Y Shi; W Zhang; R Liang; S Abraham; F S Kittrell; D Medina; M Zhang
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

5.  Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring <3 cm.

Authors:  Yuzo Takagi; Yuki Matsuoka; Tatsushi Shiomi; Kanae Nosaka; Chikako Takeda; Tomohiro Haruki; Kunio Araki; Yuji Taniguchi; Hiroshige Nakamura; Yoshihisa Umekita
Journal:  Histopathology       Date:  2014-12-22       Impact factor: 5.087

6.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

7.  Vimentin Regulates Invasiveness and Is a Poor Prognostic Marker in Non-small Cell Lung Cancer.

Authors:  Akira Tadokoro; Nobuhiro Kanaji; Dage Liu; Hiroyasu Yokomise; Reiji Haba; Tomoya Ishii; Takehiro Takagi; Naoki Watanabe; Nobuyuki Kita; Norimitsu Kadowaki; Shuji Bandoh
Journal:  Anticancer Res       Date:  2016-04       Impact factor: 2.480

8.  Expression of maspin predicts poor prognosis in breast-cancer patients.

Authors:  Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida
Journal:  Int J Cancer       Date:  2002-08-01       Impact factor: 7.396

9.  Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.

Authors:  Yuki Matsuoka; Yuzo Takagi; Kanae Nosaka; Tomohiko Sakabe; Tomohiro Haruki; Kunio Araki; Yuji Taniguchi; Tatsushi Shiomi; Hiroshige Nakamura; Yoshihisa Umekita
Journal:  Histopathology       Date:  2016-02-14       Impact factor: 5.087

10.  Identification of a putative nuclear localization signal in the tumor suppressor maspin sheds light on its nuclear import regulation.

Authors:  Jeffrey Reina; Lixin Zhou; Marcos R M Fontes; Nelly Panté; Nathalie Cella
Journal:  FEBS Open Bio       Date:  2019-05-29       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.